Healthcare Industry News:  Datex-Ohmeda 

Devices Monitoring Personnel

 News Release - November 6, 2007

Spacelabs Healthcare Announces Board and Management Appointments

HAWTHORNE, CA--(Healthcare Sales & Marketing Network)--Nov 6, 2007 -- Spacelabs Healthcare, Inc. (LSE:SLAB.L ) today announced the appointment of Mr. Joseph Davin, Group President North American Operations, and Mr. Nicholas Ong, Group President Emerging Market Operations, to the Board of Directors.

Spacelabs also announces that Mr. Nikhil Mehta has submitted his resignation as a Director and as Chief Financial Officer, effective January 21, 2008, at which time he intends to pursue other professional opportunities. In addition, Mr. Dave Tilley has also submitted his resignation as a Director. Mr. Tilley will continue to serve as the company's Chief Operating Officer primarily concentrating on the opening of the Company's new manufacturing facility in China.

Deepak Chopra, Spacelabs Healthcare's CEO, stated, "We would like to welcome Joe and Nicholas to the Board of Directors. We believe that both Joe and Nicholas will be great additions to the board due to their extensive industry experience and the critical roles that they currently play within the Company. The Board would also like to express its appreciation to Nikhil Mehta for his service and dedication and wish him the best of luck in his future endeavors."

Mr. Davin, age 52, Group President North American Operations, is currently responsible for sales, marketing and customer support teams for the U.S. and Canadian channels. Additionally, he is in charge of the product development and global marketing for the Patient Monitoring and Connectivity product group. He has been with Spacelabs Healthcare for 15 years prior to which he served as the General Manager for the Critical and Emergency Care division of Datex-Ohmeda. He has over 25 years experience in the medical equipment industry. Mr. Davin holds a Bachelor of Science degree in Biology from Bates College.

Mr. Ong, age 42, Group President Emerging Market Operations, is currently responsible for the sales, marketing, service, product development and customer support teams for the Asia/Pacific, India and Latin America channels. Prior to this appointment, Mr. Ong was responsible for the Anesthesia Delivery & Ventilation product group and Spacelabs Medical strategic marketing and business development. He previously served as President for Asia Pacific for Datex-Ohmeda and has 19 years of experience in the diagnostics and medical equipment industry. Mr. Ong holds a Bachelor of Science degree from the University of California at Berkeley and an MBA from the Henley Management College.

There are no other matters which are required to be announced with regard to these appointments under paragraph (g) of schedule 2 of the AIM rules.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc. ( is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, pulse oximeters and sensors and bone densitometers selling to hospitals, clinics and physicians offices. Additionally, the Company provides ECG laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data is recorded, analyzed, tabulated and interpreted.

The Company has established brand names in both medical devices and medical services such as "Spacelabs," "Blease" and "Del Mar Reynolds." The Company employs approximately 1,050 personnel in its 14 offices in UK, Canada, France, Germany, Finland, India, Singapore and the United States.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company's expectations, goals or intentions about the future. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update these forward-looking statements.

Source: Spacelabs

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.